🇺🇸 FDA
Patent

US 11773138

Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

granted A61KA61K38/00A61K38/04

Quick answer

US patent 11773138 (Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof) held by Theradaptive, Inc. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theradaptive, Inc.
Grant date
Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/04, A61K38/16, A61K38/1875